Advances in nasal trans-mucosal drug delivery
暂无分享,去创建一个
[1] A. Falcão,et al. Intranasal drug delivery: how, why and what for? , 2009, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[2] Osama H. Mohamed,et al. Intranasal Microemulsion of Sildenafil Citrate: In Vitro Evaluation and In Vivo Pharmacokinetic Study in Rabbits , 2009, AAPS PharmSciTech.
[3] A. Babbar,et al. Intranasal nanoemulsion based brain targeting drug delivery system of risperidone. , 2008, International journal of pharmaceutics.
[4] F. Alanazi,et al. Acyclovir liposomes for intranasal systemic delivery: development and pharmacokinetics evaluation. , 2008, Drug delivery.
[5] L. Illum,et al. Intranasal delivery: physicochemical and therapeutic aspects. , 2007, International journal of pharmaceutics.
[6] A. Bernkop‐Schnürch,et al. Transport Characteristics of a Beta Sheet Breaker Peptide Across Excised Bovine Nasal Mucosa , 2007, Drug development and industrial pharmacy.
[7] P. Diwan,et al. Muco-adhesive multivesicular liposomes as an effective carrier for transmucosal insulin delivery , 2007, Journal of drug targeting.
[8] R. Sharma,et al. Intranasal mucoadhesive microemulsions of clonazepam: preliminary studies on brain targeting. , 2006, Journal of pharmaceutical sciences.
[9] P. Giunchedi,et al. Nasal administration of carbamazepine using chitosan microspheres: in vitro/in vivo studies. , 2006, International journal of pharmaceutics.
[10] T. Kissel,et al. Insulin Containing Nanocomplexes Formed by Self-Assembly from Biodegradable Amine-Modified Poly(Vinyl Alcohol)-Graft-Poly(l-Lactide): Bioavailability and Nasal Tolerability in Rats , 2005, Pharmaceutical Research.
[11] R. Sharma,et al. Intranasal mucoadhesive microemulsions of zolmitriptan: Preliminary studies on brain-targeting , 2005, Journal of drug targeting.
[12] P. Wedlund,et al. Nipecotic Acid: Systemic Availability and Brain Delivery After Nasal Administration of Nipecotic Acid and n-Butyl Nipecotate to Rats , 2005, Pharmaceutical Research.
[13] L. Dittert,et al. Enhancement of the Systemic and CNS Specific Delivery of L-Dopa by the Nasal Administration of Its Water Soluble Prodrugs , 2000, Pharmaceutical Research.
[14] S. Davis,et al. Nasal Absorption Enhancers for Biosynthetic Human Growth Hormone in Rats , 1990, Pharmaceutical Research.
[15] V. D. Hoang,et al. Characterization of human nasal primary culture systems to investigate peptide metabolism. , 2002, International journal of pharmaceutics.
[16] A. Mitra,et al. Chemical stability, enzymatic hydrolysis, and nasal uptake of amino acid ester prodrugs of acyclovir. , 2001, Journal of pharmaceutical sciences.
[17] Y. Suzuki,et al. Mucosal drug delivery using cellulose derivatives as a functional polymer. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[18] V. Dodane,et al. Effect of chitosan on epithelial permeability and structure. , 1999, International journal of pharmaceutics.
[19] A. Perkins,et al. Evaluation of the clearance characteristics of bioadhesive systems in humans. , 1999, International journal of pharmaceutics.
[20] A. Bernkop‐Schnürch. The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[21] M. Vidgrén,et al. Nasal delivery systems and their effect on deposition and absorption. , 1998, Advanced drug delivery reviews.
[22] Romeo,et al. Optimization of systemic nasal drug delivery with pharmaceutical excipients. , 1998, Advanced drug delivery reviews.
[23] Krishnamoorthy,et al. Prodrugs for nasal drug delivery. , 1998, Advanced drug delivery reviews.
[24] S. Goswami,et al. Liposomes based nasal delivery system of nifedipine : development and characterization , 1995 .
[25] M. Miyazaki,et al. Effects of proteolytic enzyme inhibitors on nasal absorption of salmon calcitonin in rats , 1995 .
[26] H. Striebel,et al. [Pharmacokinetics of intranasal Fentanyl.]. , 1993, Schmerz.
[27] K. Ito,et al. Influence of liposomes on tryptic digestion of insulin. , 1993, Biological & pharmaceutical bulletin.
[28] M. Hussain,et al. Recovery of rat nasal mucosa from the effects of aminopeptidase inhibitors. , 1990, Journal of pharmaceutical sciences.
[29] Y. Chien,et al. Nasal systemic drug delivery , 1989 .
[30] Clive G. Wilson,et al. The influence of solution viscosity on nasal spray deposition and clearance , 1988 .
[31] V. Lee. Enzymatic barriers to peptide and protein absorption. , 1988, Critical reviews in therapeutic drug carrier systems.
[32] G. E. Peters,et al. Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity. , 1987, Journal of pharmaceutical sciences.
[33] I. Nilsson,et al. Intranasal administration of peptides: nasal deposition, biological response, and absorption of desmopressin. , 1986, Journal of pharmaceutical sciences.
[34] H. Druce. Nasal physiology. , 1986, Ear, nose, & throat journal.
[35] R. Kimura,et al. Mechanism of nasal absorption of drugs. II: Absorption of L-tyrosine and the effect of structural modification on its absorption. , 1985, Journal of pharmaceutical sciences.
[36] Y. Sakakura,et al. Macromolecular permeability of the tight junction of the human nasal mucosa. , 1985, Rhinology.
[37] J. Zuidema,et al. The effects of preservatives on the ciliary beat frequency of chicken embryo tracheas. , 1980, Rhinology.